| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.27 | 0.009 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |